Online Activities

The BURST CME™ format is an online, on-demand video program designed to deliver concise, modular education. In these modules, Uday Devgan, MD, FACS, FRCS, reviews presbyopia-correcting intraocular lenses (IOLs) and toric IOLs for patients with astigmatism. Topics discussed include the...

Schizophrenia represents a major psychiatric disorder characterized by symptoms that frequently compromise daily functioning and diminish overall quality of life. While effective management can lead to improved patient outcomes, many individuals continue to struggle with persistent or residual symptoms, medication...

In this online, on-demand educational video, Steven J Greene, MD, and Anu Lala, MD, will discuss the intersection of CKD and heart failure and the role diabetes plays in these diseases, current guidelines for CKD testing in at-risk patients, and...

In generalized myasthenia gravis (gMG), pathogenic antibodies activate the terminal complement cascade at the neuromuscular junction, leading to membrane attack complex–mediated damage of the postsynaptic membrane. Complement C5 inhibition directly blocks this mechanism, addressing a central driver of disease rather...

Despite robust evidence supporting aggressive LDL-cholesterol reduction for the prevention of atherosclerotic cardiovascular disease (ASCVD), substantial gaps persist between guideline recommendations and real-world treatment intensification. Many high-risk and very high-risk patients fail to achieve recommended LDL-C thresholds, leaving them vulnerable...

This online, on-demand virtual symposium brings together renowned experts in paroxysmal nocturnal hemoglobinuria (PNH). In this educational program, these experts engage in an in-depth exploration of PNH, with a focus on pathophysiology and disease burden, clinical manifestations, best practices for...

Recent advances in the treatment of presbyopia have focused on pharmacological agents as a novel therapeutic strategy that offers noninvasive, reversible options capable of enhancing depth of focus without altering the natural lens structure. As new and emerging pharmacological therapies...

This educational activity is an archive of the live presentation held on February 12, 2026. For more information about this educational activity, the faculty, and disclosures, please click here. Target Audience This educational activity is directed toward rheumatologists, nurse practitioners,...

In this online, on-demand educational video, Gus Alva, MD, DFAPA; and Erin Crown, MHS, PA-C will discuss the utility of oral antipsychotics for the treatment of newly diagnosed and previously treated patients with schizophrenia. The expert faculty will review the...

Research revealing that overexpression of TL1A drives key pathological pathways in inflammatory bowel disease (IBD) has accelerated the development of biologic therapies aimed at inhibiting this ligand. Early studies of investigational anti-TL1A agents—including tulisokibart, afimkibart, and duvakitug—demonstrate encouraging outcomes in...